2919 results found
NHMRC has rigorous standards in place to ensure that guidelines and advice are high quality and based on the best available scientific evidence.
There are many steps involved when developing guidelines with engagement from a variety of different stakeholders. They are developed by multidisciplinary committees that follow a rigorous evidence-based approach. They are informed by the judgement of evidence by experts, and the views of consumers, community groups and other people affected by the guidelines.
To support the development of the highest quality guidelines and advice, NHMRC has robust processes in place to manage conflict of interest and to use recognised tools to assess the evidence for quality and bias.
The Principles are high-level, guiding statements, that underpin NHMRC's peer review processes and will apply to all NHMRC funding schemes.
NHMRC offers a range of funding pathways, depending on your objectives, funding amount, timeframes and other preferences. The Partnering Decision Tree below presents potential partners with options to assist in making a decision on the type of funding model to adopt.
The major national health issues outlined below are NHMRC's health priorities for the 2024–2027 triennium.
On 15 November 2022, the National Health and Medical Research Council (NHMRC) co-hosted an online workshop with the CHF to commence the review of the Statement on Consumer and Community Involvement in Health and Medical Research (2016) (the Statement). See also consumer and community engagement
Multidisciplinary and multi-institution research is often the key to scientific advancement. NHMRC supports collaborative approaches to health and medical research. We provide assistance to Australian researchers in collaborative research projects, facilitate collaborative networks and international research partnerships, and researchers can explore opportunities to work with us or use our facilities.
Within the framework of the Corporate Plan, the National Health and Medical Research Council (NHMRC) has established a strategy to guide new and existing activities with our international partners.
In conjunction with the Australian Clinical Trials Alliance, we developed the clinical trials competencies to be used in the development of detailed curricula and training courses by universities, Colleges and other registered training organisations*.
To improve clinical trial start-up times, we developed the Good Practice Process for Site Assessment and Authorisation Phases of Clinical Trial Research Governance (the Good Practice Process).
The NHMRC and ARC Statement on Open Researcher and Contributor ID explains NHMRC's position on the ORCID researcher identifier.
The Statement on consumer and community involvement in health and medical research (The Statement), co-authored by the National Health and Medical Research Council (NHMRC) and the Consumers Health Forum of Australia (CHF), aims to guide research institutions, researchers, consumers and community members in the active involvement of consumers and community members in all aspects of health and medical research.
The Australian Government's Boosting Dementia Research Initiative invested $200 million over 5 years from 2014 to 2019 to accelerate research, enhance collaboration and promote advances in dementia research and treatment. The Boosting Dementia Research Initiative (BDRI) consisted of two main elements:
The Targeted Call for Research (TCR): Anal Cancer 2025 grant opportunity aims to fund research aimed at improving awareness and to provide further guidance for the prevention, diagnosis and treatment of anal cancer for both consumers and healthcare professionals. Its focus may encompass, but is not limited to, the development and implementation of screening methods, innovative prevention strategies, testing technologies, and health promotion approaches to more broadly address anal cancer.